%0 Journal Article
%T Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project
%A Amy Turner
%A Brittany N. Beyer
%A Chingying Huang Smith
%A Jun Liao
%A Lisa V. Kalman
%A Lorraine H. Toji
%A Paul Hujsak
%A Praful Aggarwal
%A Rachel Lorier
%A Robin E. Everts
%A Ruth Epstein-Baak
%A Ruth Kornreich
%A Stuart A. Scott
%A Ulrich Broeckel
%A Victoria M. Pratt
%J The Journal of Molecular Diagnostics
%D 2016
%R 10.1016/j.jmoldx.2015.08.005
%X Pharmacogenetic testing is increasingly available from clinical laboratories. However,
only a limited number of quality control and other reference materials are currently
available to support clinical testing. To address this need, the Centers for Disease
Control and Prevention¨Cbased Genetic Testing Reference Material Coordination Program,
in collaboration with members of the pharmacogenetic testing community and the Coriell
Cell Repositories, has characterized 137 genomic DNA samples for 28 genes commonly
genotyped by pharmacogenetic testing assays (CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8,
CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP4F2, DPYD, GSTM1, GSTP1, GSTT1,
NAT1, NAT2, SLC15A2, SLC22A2, SLCO1B1, SLCO2B1, TPMT, UGT1A1, UGT2B7, UGT2B15, UGT2B17,
and VKORC1).
%U https://jmd.amjpathol.org/article/S1525-1578(15)00227-5/fulltext